Shenzhen Neptunus Interlong Bio-technique Company Limited (08329.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.7x

Market Cap

HKD 164.52M

MomentumView details →

1D Return

−6.67%

YTD Return

−38.36%

RSI (14)

37.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.7x

Market Cap

HKD 164.52M

RSI (14)

37.8

MomentumView details →

1D Return

−6.67%

YTD Return

−38.36%

ProfitabilityView details →

Gross Margin

29.08%

Net Margin

−4.39%

EBITDA Margin

4.31%

ROE (TTM)

−7.54%

ROA (TTM)

−4.61%

Asset Turnover

1.05x

GrowthView details →

Revenue YoY

+13.21%

EPS YoY

—

FCF YoY

+322.47%

Revenue CAGR 3Y

−0.50%

EPS CAGR 3Y

—

EBITDA YoY

+26.55%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

2.00x

Quick Ratio

1.50x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.12B

Net Income (TTM)

−49.34M

Op. CF (TTM)

144.90M

Latest newsMore news →

No recent news for 08329.HK.

Similar companies

Organigram Global Inc.OGI Lifecore Biomedical, Inc.LFCR Assertio Holdings, Inc.ASRT Extrawell Pharmaceutical Holdings Limited00858.HK PuraPharm Corporation Limited01498.HK Tianda Pharmaceuticals Limited00455.HK Find similar companies →

Latest newsMore news →

No recent news for 08329.HK.